Posts

Showing posts from January, 2021

Aerosol Propellants Market Will Secure CAGR of 5% from 2016 to 2025

The AerosolPropellants market was estimated at USD 7.26 Billion in the year 2015. The market is likely to increase during the forecast period, owing to the development and utilization of superior propellant formulations that offer improved product dispensing capabilities. The industry comprises numerous manufacturers across the globe, who are focusing on the development of advanced products to expand their business and hence enhance their presence as key players and improve their global reach. The industry is likely to see substantial growth over the years ahead, as a result of increased penetration of aerosol cans in various application sectors including medical, automotive, food processing and paints. Owing to the heavy demand of aerosol cans in health and hygiene associated products like insect repellants and air fresheners, this in turn is likely to increase the demand for propellants over the years ahead. Additionally, rapid urbanization along with infrastructural developments

Global Cystic Fibrosis Therapeutics Market Regional Analysis from 2021-2025

  The global CysticFibrosis Therapeutics market is subject to witness a substantial growth due to the growing occurrence of cystic fibrosis (CF) and increasing demand of advanced treatment associated with the disorder. Additionally, increase in the research & development and introduction of novel products in the market are anticipated to boost the market growth in the forecast period. Increase in number of initiatives and schemes carried out by government authorities and leading industry players to promote early adoption of cystic fibrosis therapeutics coupled with presence of favorable reimbursement policies are considered as some of the major factors driving market growth, in the recent years. The cystic fibrosis therapeutics market is estimated to grow at a substantial CAGR in the forecast period, providing numerous opportunities for market players to invest in research and development in the cystic fibrosis therapeutics market. As per Cystic Fibrosis Foundation (CPF), the n